ONE Bio Corp.
ONBI
$0.02
$0.029,900.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | 6.13% | 29.98% | 72.00% | 136.92% | 340.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.13% | 29.98% | 72.00% | 136.92% | 340.73% |
| Cost of Revenue | -3.90% | 23.52% | 71.80% | 166.11% | 534.26% |
| Gross Profit | 22.45% | 39.85% | 72.29% | 101.57% | 194.45% |
| SG&A Expenses | 43.27% | 89.89% | 128.76% | 188.04% | 230.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.99% | 32.09% | 78.12% | 164.22% | 426.63% |
| Operating Income | 14.73% | 24.76% | 57.57% | 83.43% | 204.49% |
| Income Before Tax | 6.69% | 20.94% | 49.38% | 65.08% | 183.58% |
| Income Tax Expenses | 17.13% | 28.55% | 47.81% | 61.85% | 170.00% |
| Earnings from Continuing Operations | 2.88% | 18.13% | 49.99% | 66.30% | 188.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 94.32% | 82.39% | 79.06% | 25.85% | -298.94% |
| Net Income | 8.85% | 26.39% | 62.65% | 73.21% | 151.09% |
| EBIT | 14.73% | 24.76% | 57.57% | 83.43% | 204.49% |
| EBITDA | 15.69% | 25.24% | 57.02% | 81.96% | 201.92% |
| EPS Basic | -3.62% | 12.54% | 45.21% | -27.45% | -9.23% |
| Normalized Basic EPS | 5.90% | 16.60% | 46.60% | -27.28% | -9.70% |
| EPS Diluted | 0.26% | 16.20% | 42.02% | -33.26% | -15.94% |
| Normalized Diluted EPS | 9.15% | 20.07% | 42.50% | -33.56% | -17.59% |
| Average Basic Shares Outstanding | 14.98% | 15.08% | 17.05% | 48.96% | -13.15% |
| Average Diluted Shares Outstanding | 10.87% | 11.46% | 20.64% | 62.04% | -4.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |